Extrapulmonary lymphangioleiomyomatosis in pelvic and paraaortic lymph nodes associated with uterine cancer: a report of 3 cases.

We report 3 cases of extrapulmonary lymphangioleiomyomatosis incidentally found in pelvic and paraaortic lymph nodes in association with uterine cancers. Three women, 47-year-old, 59-year-old, and 71-year-old, respectively, had uterine cancers and underwent hysterectomy, bilateral salpingo-oophorectomy, and pelvic and paraaortic lymph node excision. None of the 3 patients had tuberous sclerosis complex or lymphangioleiomyomatosis in other organs. None had any history of extrinsic hormonal administration. The postoperative pathologic diagnoses were uterine cervical squamous cell carcinoma for the first patient and endometrioid adenocarcinomas for the second and the third patients. Besides these malignant lesions, all 3 patients showed spindle cell proliferation, 2 to 5 mm in size, in 1 to 8 foci of the pelvic and paraaortic lymph nodes. The spindle cells having small polygonal nuclei and inconspicuous nucleoli with palely eosinophilic cytoplasm, reminiscent of immature smooth muscle cells, proliferated in nested and whorling patterns. Neither cellular atypia nor mitotic figures were observed. Immunohistochemically, these spindle cells were positive for α-Smooth Muscle Actin, Desmin, HMB45, Microphthalmia Transcription Factor, Estrogen receptor, and Progesterone receptor. And the network of the vascular-like channels surrounded by these spindle cells was positive for D2-40. From the pathologic and immunohistochemical findings, the spindle cell proliferation in the lymph nodes is best interpreted as lymphangioleiomyomatosis.

[1]  A. Folpe,et al.  Perivascular epithelioid cell neoplasms: pathology and pathogenesis. , 2010, Human pathology.

[2]  P. Russell,et al.  Pelvic lymphangioleiomyomatosis associated with endosalpingiosis. , 2009, Pathology.

[3]  M. Sugimoto,et al.  Retroperitoneal lymphangioleiomyomatosis associated with endosalpingiosis , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[4]  C. Fletcher,et al.  PEComa: what do we know so far? , 2006, Histopathology.

[5]  Y. Fukuchi,et al.  Lymphangiogenesis in Lymphangioleiomyomatosis: Its Implication in the Progression of Lymphangioleiomyomatosis , 2004, The American journal of surgical pathology.

[6]  W. Travis,et al.  Association of Lymphangioleiomyomatosis (LAM) with Endosalpingiosis in the Retroperitoneal Lymph Nodes: Report of Two Cases , 2001, International journal of surgical pathology.

[7]  W. Travis,et al.  Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases. , 2000, Human pathology.

[8]  E. Henske,et al.  Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis. , 2000, Chest.

[9]  E. Henske,et al.  Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. , 1998, American journal of human genetics.

[10]  G. Zamboni,et al.  Perivascular epithelioid cell. , 1996, The American journal of surgical pathology.

[11]  G. Martinelli,et al.  Leiomyomatosis in pelvic lymph nodes , 1992, Histopathology.

[12]  R. Coombes,et al.  Pulmonary lymphangioleiomyomatosis and steroid receptors. An immunocytochemical study. , 1990, American journal of clinical pathology.

[13]  Y. Sato,et al.  Leiomyomatosis in the pelvic lymph node and peritoneum , 1984, Acta pathologica japonica.

[14]  F. Tavassoli,et al.  Peritoneal Leiomyomatosis (Leiomyomatosis Peritonealis Disseminata): A Clinicopathologic Study of 20 Cases with Ultrastructural Observations , 1982, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.